Abstract
Although it is generally accepted that antipsychotic treatment improves the negative symptoms of schizophrenia in the context of improvement of positive symptoms, exactly how and to what extent they effect “primary” negative symptoms remains controversial. Antipsychotic treatment may reduce only those negative symptoms secondary to positive or depressive symptoms, and may have minimal, if any effect, on negative symptoms that represent a primary psychopathological trait manifestation of schizophrenia. In an effort to further examine this issue, we prospectively assessed negative, positive, depressive, and extrapyramidal symptoms following the discontinuation of antipsychotic medication. Fifty-nine DSM III-R schizophrenic patients underwent a three-week drug wash as part of our neuroimaging protocols. We assessed psychopathological status and adverse effects utilizing various rating instruments (i.e., Scale for Assessment of Positive Symptoms [SAPS], Scale for Assessment of Negative Symptoms [SANS], Hamilton Rating Scale for Depression, and Simpson-Angus Extrapyramidal) at baseline and weekly during this three-week period. Negative symptoms, as measured by the SANS, worsened significantly during the three-week drug wash. Positive symptoms showed a less consistent change with symptoms of disorganization worsening and with psychotic symptoms remaining the same. The changes in negative symptoms during the drug-free period were correlated with the changes in psychosis and disorganization, but not with changes in depression or extrapyramidal side effects. We were not able to substantiate if the worsening in negative symptoms was a direct result of the worsening of positive symptoms or if they were changing simultaneously, but independent of each other.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Additional information
Address reprint requests to: Del D. Miller, Pharm.D., M.D., University of Iowa Hospitals and Clinics, Department of Psychiatry Administration, Rm 2887 JPP, 200 Hawkins Drive, Iowa City, IA 52242-1057.
Rights and permissions
About this article
Cite this article
Miller, D., Flaum, M., Arndt, S. et al. Effect of Antipsychotic Withdrawal on Negative Symptoms in Schizophrenia. Neuropsychopharmacol 11, 11–20 (1994). https://doi.org/10.1038/npp.1994.31
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/npp.1994.31
Keywords
This article is cited by
-
Lack of association between dopaminergic antagonism and negative symptoms in schizophrenia: a positron emission tomography dopamine D2/3 receptor occupancy study
Psychopharmacology (2016)
-
Antipsychotics and Amotivation
Neuropsychopharmacology (2015)
-
Relapse following clozapine withdrawal: effect of neuroleptic drugs and cyproheptadine
Psychopharmacology (1996)